Inspira Technologies rises on clinical study pact for blood sensor

Qtrex Quantum

14/12/2022 15:31

** Shares of medical device maker Inspira Technologies Oxy
BHN Ltd  IINN.O  rise 3.3% to $1.08 in early trading hours
    ** Co signs an agreement with Sheba Medical Center in Israel
to conduct a clinical study of its Hyla blood sensor 
    ** Study aims to further evaluate sensor's capabilities to
measure blood gases in a non-invasive and continuous manner -
Inspira 
    ** Study will be performed in an operating room setting in
patients undergoing open heart surgery using a cardiopulmonary
bypass machine, says Inspira
    ** Trial results are expected to have a significant
contribution to the product's development - co
    ** Study is expected to start in Q1 2023, according to
Inspira
    ** Inspira stock down 72.8% YTD
 (Reporting by Aditya Samal)
 ((Aditya.Samal@thomsonreuters.com))